Evercore Wealth Management LLC lowered its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 18.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,705 shares of the pharmacy operator’s stock after selling 3,317 shares during the quarter. Evercore Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $1,072,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. raised its position in shares of Walgreens Boots Alliance by 1.5% during the second quarter. BlackRock Inc. now owns 53,148,612 shares of the pharmacy operator’s stock worth $3,189,715,000 after purchasing an additional 771,307 shares during the period. Franklin Resources Inc. raised its position in shares of Walgreens Boots Alliance by 21.5% during the third quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock worth $1,369,796,000 after purchasing an additional 3,318,524 shares during the period. Bank of New York Mellon Corp raised its position in shares of Walgreens Boots Alliance by 71,970.7% during the third quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after purchasing an additional 11,624,703 shares during the period. LSV Asset Management raised its position in shares of Walgreens Boots Alliance by 28.5% during the third quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock worth $815,307,000 after purchasing an additional 2,479,681 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in shares of Walgreens Boots Alliance by 11.5% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock worth $666,804,000 after purchasing an additional 1,143,819 shares during the period. 62.59% of the stock is currently owned by institutional investors.

A number of equities research analysts recently issued reports on the company. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Tuesday, September 25th. BidaskClub lowered Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 28th. Loop Capital lifted their target price on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, October 12th. Finally, Barclays lifted their target price on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research report on Friday, October 12th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $79.11.

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 7,050 shares of the business’s stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total transaction of $555,610.50. Following the transaction, the director now owns 5,709 shares of the company’s stock, valued at approximately $449,926.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 1st. The stock was sold at an average price of $79.48, for a total value of $217,457.28. Following the transaction, the director now directly owns 8,207 shares in the company, valued at approximately $652,292.36. The disclosure for this sale can be found here. Insiders have sold a total of 73,756 shares of company stock worth $5,824,194 in the last ninety days. Insiders own 14.80% of the company’s stock.

NASDAQ:WBA opened at $81.19 on Friday. The company has a market cap of $78.61 billion, a price-to-earnings ratio of 13.49, a P/E/G ratio of 1.29 and a beta of 0.76. Walgreens Boots Alliance Inc has a twelve month low of $59.07 and a twelve month high of $86.31. The company has a current ratio of 0.82, a quick ratio of 0.38 and a debt-to-equity ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion for the quarter, compared to analyst estimates of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. Research analysts forecast that Walgreens Boots Alliance Inc will post 6.54 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 2.17%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.

TRADEMARK VIOLATION NOTICE: This article was published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-evercore-wealth-management-llc/2669740.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: Stock Split

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.